Recall Z-0610-2019
Diagnostica Stago, Inc. · initiated November 14, 2018
Class II – products that might cause a temporary health problem or pose a slight threat of a serious nature
Product
Staclot LA (REF 00600) The Staclot LA and Staclot LA 20 test kits are reagent systems designed for the qualitative detection of lupus anticoagulants (LA) in plasma by the use of hexagonal HII phase phospholipid molecules (1, 2).
Codes / lots: Lot #s 251918, 252751
Reason for recall
There have been reports of shortened (T1-T2) results, where some instances of result recovery outside of the range of less than or equal to 15 seconds.
FDA-determined cause: Nonconforming Material/Component
Action taken
The firm, STAGO, sent a "Field Safety Notice" to its customers on 11/14/18. The notices describe the product, problem and actions to be taken. The customers were instructed to do the following: If you have any lots listed in the appendix in your laboratory, stop using and destroy the concerned kits; contact our sales administration team (1-800-222-2624 prompt #3) as soon as possible in order to obtain a replacement lot and complete the attached coupon acknowledging receipt of the letter. For additional information, please contact the STAGO hotline (1-800-725-0607) or email: Donald.kraft@us.stago.com or 1-973-631-1200 ext 4104.
Details
- Recall number
- Z-0610-2019
- Initiated
- November 14, 2018
- Terminated
- June 8, 2020
- Product code
- GFO – Activated Partial Thromboplastin
- Quantity
- 22342 total
- Distribution
- US Nationwide Distribution
- Recalling firm
- Diagnostica Stago, Inc., Parsippany, NJ
Other products in the same recall event
| Recall | Product | Initiated |
|---|---|---|
| Z-0611-2019 Class II | Staclot LA 20 (REF 00594) The Staclot LA and Staclot LA 20 test kits are reagent systems…There have been reports of shortened (T1-T2) results, where some instances of result recovery outside of the… | 11/14/2018Terminated |